Abstract
Purpose: This study aimed to evaluate the Pharmacovigilance (PV) and severity of hypersensitivity reactions induced by non-ionic Iodinated Contrast Media (ICM) in the radiology diagnosis reported to the United States Food and Drug Administration Adverse Event Reporting System (FAERS).
Methods: We retrospectively reviewed the reports of ICM-induced hypersensitivity reactions submitted to the FAERS database between January 2015 and January 2023 and conducted a disproportionality analysis. The seven most common non-ionic ICM, including iohexol, iopamidol, ioversol, iopromide, iomeprol, iobitridol, and iodixanol, were chiefly analyzed. Our primary endpoint was the PV of non-ionic ICM-induced total hypersensitivity events. STATA 17.0 MP was used for statistical analysis.
Results: In total, 35357 reports of adverse reaction events in radiology diagnosis were retrieved from the FAERS database. Among them, 6181 reports were on hypersensitivity reaction events (mean age: 57.1 ± 17.8 years). The hypersensitivity reaction-related PV signal was detected for iohexol, ioversol, iopromide, iomeprol, iobitridol, and iodixanol, but not for iopamidol. The proportion of iomeprol-induced hypersensitivity reactions and the probability of ioversol-induced severe hypersensitivity reactions have been found to be significantly increased.
Conclusion: The probability and severity of hypersensitivity reaction events in non-ionic ICM are different. Iohexol, ioversol, iopromide, iomeprol, iobitridol, and iodixanol have higher risks compared to iopamidol. In addition, the constituent ratio of hypersensitivity reactions induced by iomeprol is significantly increased, and the associated probability induced by ioversol is significantly increased.
Keywords: Hypersensitivity reactions, Iodinated contrast media, Disproportionality analysis, Food and drug administration adverse event reporting system, Radiology, FAERS.
Call for Papers in Thematic Issues
Advancements and Applications of Photon Counting CT: Transforming Imaging Precision and Quantification
Photon Counting Computed Tomography (CT) represents a transformative advancement in medical imaging technology, offering unprecedented levels of precision and diagnostic capability. This special issue will explore the latest innovations and applications of photon counting CT, highlighting its advantages over traditional energy-integrating detectors. The scope includes an in-depth examination of its ...read more
Advancements in Deep Learning based Medical Image and Signal Processing for Healthcare Applications
The accurate predication from medical data (signals and images) analytics will be achieved through the use of cutting-edge AI tools for tailoring medical treatment to each patient. When the agents are done analysing the user's health data, the user can consult with the agents to receive advice and the most ...read more
AI-Driven Diagnostics in Radiology and Medical Imaging
Medical imaging data, such as X-rays, MRIs, ultrasounds, CT scans, and DXAs, can be analysed by AI algorithms to help healthcare professionals identify and diagnose diseases more rapidly and accurately. Among the most cutting-edge applications of artificial intelligence (AI) in healthcare are imaging-related applications like cancer detection. AI could revolutionise ...read more
Applying medical image processing techniques for early cancer detection in mammograms
Breast cancer survival and successful treatment are significantly boosted by early identification. Breast cancer screening is most commonly accomplished with mammography. The radiologist's experience and the image quality, among several other factors, might affect how well a mammogram is interpreted. Enhancing mammography analysis and increasing cancer early detection are made ...read more
23
